共查询到20条相似文献,搜索用时 453 毫秒
1.
Maria Mota Simona Georgiana Popa Eugen Mota Adina Mitrea Doina Catrinoiu Dan Mircea Cheta Cristian Guja Nicolae Hancu Constantin Ionescu‐Tirgoviste Radu Lichiardopol Bogdan Mircea Mihai Amorin Remus Popa Cornelia Zetu Cornelia Gabriela Bala Gabriela Roman Cristian Serafinceanu Viorel Serban Romulus Timar Ioan Andrei Veresiu Adrian Radu Vlad 《Journal of Diabetes》2016,8(3):336-344
2.
3.
Diabetes mellitus prevalence is increasing in South Asians but is stable in Chinese living in Singapore and Mauritius 下载免费PDF全文
Kristin H.X. Tan Elizabeth L.M. Barr Vira Koshkina Stefan Ma Sudhir Kowlessur Dianna J. Magliano Stefan Söderberg Kee Seng Chia Paul Zimmet Wei‐Yen Lim 《Journal of Diabetes》2017,9(9):855-864
4.
5.
6.
Anoop Misra Hema Gopalan Ranil Jayawardena Andrew P. Hills Mario Soares Alfredo A. Reza‐Albarrán Kaushik L. Ramaiya 《Journal of Diabetes》2019,11(7):522-539
There has been a rapid escalation of type 2 diabetes (T2D) in developing countries, with varied prevalence according to rural vs urban habitat and degree of urbanization. Some ethnic groups (eg, South Asians, other Asians, and Africans), develop diabetes a decade earlier and at a lower body mass index than Whites, have prominent abdominal obesity, and accelerated the conversion from prediabetes to diabetes. The burden of complications, both macro‐ and microvascular, is substantial, but also varies according to populations. The syndemics of diabetes with HIV or tuberculosis are prevalent in many developing countries and predispose to each other. Screening for diabetes in large populations living in diverse habitats may not be cost‐effective, but targeted high‐risk screening may have a place. The cost of diagnostic tests and scarcity of health manpower pose substantial hurdles in the diagnosis and monitoring of patients. Efforts for prevention remain rudimentary in most developing countries. The quality of care is largely poor; hence, a substantial number of patients do not achieve treatment goals. This is further amplified by a delay in seeking treatment, “fatalistic attitudes”, high cost and non‐availability of drugs and insulins. To counter these numerous challenges, a renewed political commitment and mandate for health promotion and disease prevention are urgently needed. Several low‐cost innovative approaches have been trialed with encouraging outcomes, including training and deployment of non‐medical allied health professionals and the use of mobile phones and telemedicine to deliver simple health messages for the prevention and management of T2D. 相似文献
7.
Prevalence of and risk factors for diabetic ketosis in Chinese diabetic patients with random blood glucose levels >13.9 mmol/L: Results from the CHina study in prEvalence of diabetiC Ketosis (CHECK) study 下载免费PDF全文
Leili Gao Yufeng Li Dadong Fei Li Ma Shuchun Chen Bo Feng Qing Su Linong Ji 《Journal of Diabetes》2018,10(3):249-255
8.
Glycemic status and chronic kidney disease in Chinese adults: Findings from the REACTION study
下载免费PDF全文
Lin Lin Jieli Lu Lulu Chen Yiming Mu Zhen Ye Chao Liu Gang Chen Lixin Shi Jiajun Zhao Qiang Li Tao Yang Li Yan Qin Wan Shengli Wu Yan Liu Guixia Wang Zuojie Luo Xulei Tang Yanan Huo Zhengnan Gao Qing Su Youmin Wang Guijun Qin Huacong Deng Xuefeng Yu Feixia Shen Li Chen Liebin Zhao Yu Xu Min Xu Kui Peng Rui Du Meng Dai Mian Li Tiange Wang Zhiyun Zhao Shenghan Lai Donghui Li Yufang Bi Weiqing Wang Guang Ning 《Journal of Diabetes》2017,9(9):837-845
9.
10.
11.
12.
13.
14.
Louise J. Maple‐Brown Greta Lindenmayer Federica Barzi Cherie Whitbread Christine Connors Elizabeth Moore Jacqueline Boyle Marie Kirkwood I‐Lynn Lee Danielle Longmore Paula van Dokkum Mary Wicks Michelle Dowden Chrissie Inglis Margaret Cotter Renae Kirkham Sumaria Corpus Sridhar Chitturi Sujatha Thomas Kerin O'Dea Paul Zimmet Jeremy Oats Harold D. McIntyre Alex Brown Jonathan E. Shaw 《Journal of Diabetes》2019,11(9):761-770
15.
16.
Prevalence of diabetes and impaired fasting glucose in Costa Rica: Costa Rican National Cardiovascular Risk Factors Survey, 2010 下载免费PDF全文
Roy Wong‐McClure Edward W. Gregg Alberto Barcelo Laura Sanabria‐Lopez Kahye Lee Leandra Abarca‐Gomez Marvin Cervantes‐Loaiza Elizabeth T. Luman 《Journal of Diabetes》2016,8(5):686-692
17.
18.
Hypoglycemia is a frequent occurrence in patients with diabetes who are treated with insulin and insulin secretagogues. Hypoglycemia is the limiting factor that prevents patients from achieving the glycemic control known to reduce the microvascular complications of diabetes. Recurrent episodes of hypoglycemia can lead to impaired awareness of hypoglycemia where the first symptom of a low blood sugar is unconsciousness. The fear of hypoglycemia has a significant effect on the quality of life of patients and their families. In the acute setting, hypoglycemia can kill, and clinical trials have demonstrated that a single episode of severe hypoglycemia increases the risk of subsequent mortality and cardiovascular events. Clinicians must make efforts to recognize and prevent hypoglycemia in order to prevent the adverse events associated with this event. Patient education is central to these efforts. Recent developments in glucose monitoring and drug development have provided more approaches that can be used to reduce the risk of hypoglycemia in patients with diabetes. 相似文献